FARALLON CAPITAL MANAGEMENT, L.L.C. Diversified Active

Location: San Francisco, CA

CIK: 0000909661 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Nov 15, 2021

Total Value: $14.46B

Holdings (122)

IQV IQVIA HLDGS INC 3.8%
Value $556M Shares 3,526,636 Share Price $157.63 Est. Cost/Share — Unrealized @ Report Date —
GOOG ALPHABET INC 3.7%
Value $533M Shares 362,629 Share Price $1469.60 Est. Cost/Share — Unrealized @ Report Date —
— IMMUNOMEDICS INC 3.4%
Value $498M Shares 5,860,000 Share Price $85.03 Est. Cost/Share — Unrealized @ Report Date —
TMO THERMO FISHER SCIENTIFIC INC 3.3%
Value $484M Shares 1,095,578 Share Price $441.52 Est. Cost/Share — Unrealized @ Report Date —
FIS FIDELITY NATL INFORMATION SV 3.2%
Value $466M Shares 3,162,858 Share Price $147.21 Est. Cost/Share — Unrealized @ Report Date —
CHTR CHARTER COMMUNICATIONS INC N 3.2%
Value $458M Shares 733,191 Share Price $624.34 Est. Cost/Share — Unrealized @ Report Date —
TMUS T-MOBILE US INC 2.9%
Value $416M Shares 3,636,981 Share Price $114.36 Est. Cost/Share — Unrealized @ Report Date —
CNC CENTENE CORP DEL 2.8%
Value $411M Shares 7,050,000 Share Price $58.33 Est. Cost/Share — Unrealized @ Report Date —
META FACEBOOK INC 2.8%
Value $404M Shares 1,542,045 Share Price $261.90 Est. Cost/Share — Unrealized @ Report Date —
ABBV ABBVIE INC 2.6%
Value $372M Shares 4,250,000 Share Price $87.59 Est. Cost/Share — Unrealized @ Report Date —
AON AON PLC 2.5%
Value $362M Shares 1,756,344 Share Price $206.30 Est. Cost/Share — Unrealized @ Report Date —
V VISA INC 2.4%
Value $343M Shares 1,716,704 Share Price $199.97 Est. Cost/Share — Unrealized @ Report Date —
ELV ANTHEM INC 2.4%
Value $342M Shares 1,275,000 Share Price $268.59 Est. Cost/Share — Unrealized @ Report Date —
WAB WABTEC 2.3%
Value $337M Shares 5,439,551 Share Price $61.88 Est. Cost/Share — Unrealized @ Report Date —
MSFT MICROSOFT CORP 2.2%
Value $324M Shares 1,540,978 Share Price $210.33 Est. Cost/Share — Unrealized @ Report Date —
EMB ISHARES TR 2.2%
Value $320M Shares 288,900 Share Price $1108.90 Est. Cost/Share — Unrealized @ Report Date —
BSX BOSTON SCIENTIFIC CORP 2.2%
Value $316M Shares 8,275,919 Share Price $38.21 Est. Cost/Share — Unrealized @ Report Date —
NYT NEW YORK TIMES CO 2.1%
Value $304M Shares 7,106,042 Share Price $42.79 Est. Cost/Share — Unrealized @ Report Date —
— IHS MARKIT LTD 2.1%
Value $299M Shares 3,812,944 Share Price $78.51 Est. Cost/Share — Unrealized @ Report Date —
— ACCELERON PHARMA INC 2.0%
Value $293M Shares 2,600,000 Share Price $112.53 Est. Cost/Share — Unrealized @ Report Date —
SHW SHERWIN WILLIAMS CO 2.0%
Value $283M Shares 405,786 Share Price $696.74 Est. Cost/Share — Unrealized @ Report Date —
— TIFFANY & CO NEW 1.8%
Value $265M Shares 2,287,000 Share Price $115.85 Est. Cost/Share — Unrealized @ Report Date —
EXEL EXELIXIS INC 1.8%
Value $263M Shares 10,750,000 Share Price $24.45 Est. Cost/Share — Unrealized @ Report Date —
BMY BRISTOL-MYERS SQUIBB CO 1.6%
Value $226M Shares 3,750,000 Share Price $60.29 Est. Cost/Share — Unrealized @ Report Date —
PANW PALO ALTO NETWORKS INC 1.5%
Value $217M Shares 887,892 Share Price $244.75 Est. Cost/Share — Unrealized @ Report Date —
— NEW ORIENTAL ED & TECHNOLOGY 1.4%
Value $205M Shares 1,368,778 Share Price $149.50 Est. Cost/Share — Unrealized @ Report Date —
BX BLACKSTONE GROUP INC 1.4%
Value $200M Shares 3,829,336 Share Price $52.20 Est. Cost/Share — Unrealized @ Report Date —
IOVA IOVANCE BIOTHERAPEUTICS INC 1.4%
Value $196M Shares 5,955,000 Share Price $32.92 Est. Cost/Share — Unrealized @ Report Date —
ASND ASCENDIS PHARMA A/S 1.3%
Value $193M Shares 1,250,000 Share Price $154.32 Est. Cost/Share — Unrealized @ Report Date —
BABA ALIBABA GROUP HLDG LTD 1.2%
Value $180M Shares 612,585 Share Price $293.98 Est. Cost/Share — Unrealized @ Report Date —
GD GENERAL DYNAMICS CORP 1.2%
Value $177M Shares 1,277,107 Share Price $138.43 Est. Cost/Share — Unrealized @ Report Date —
CRM SALESFORCE COM INC 1.2%
Value $176M Shares 698,315 Share Price $251.32 Est. Cost/Share — Unrealized @ Report Date —
ALNY ALNYLAM PHARMACEUTICALS INC 1.2%
Value $175M Shares 1,200,000 Share Price $145.60 Est. Cost/Share — Unrealized @ Report Date —
— MYOKARDIA INC 1.2%
Value $167M Shares 1,225,000 Share Price $136.33 Est. Cost/Share — Unrealized @ Report Date —
— WRIGHT MED GROUP N V 1.1%
Value $156M Shares 5,097,546 Share Price $30.54 Est. Cost/Share — Unrealized @ Report Date —
TRU TRANSUNION 1.1%
Value $153M Shares 1,814,132 Share Price $84.13 Est. Cost/Share — Unrealized @ Report Date —
EQIX EQUINIX INC 1.1%
Value $152M Shares 200,164 Share Price $760.13 Est. Cost/Share — Unrealized @ Report Date —
— MIRATI THERAPEUTICS INC 1.0%
Value $145M Shares 875,000 Share Price $166.05 Est. Cost/Share — Unrealized @ Report Date —
HLT HILTON WORLDWIDE HLDGS INC 0.9%
Value $132M Shares 1,545,877 Share Price $85.32 Est. Cost/Share — Unrealized @ Report Date —
— PLAYA HOTELS & RESORTS NV 0.9%
Value $128M Shares 30,606,930 Share Price $4.19 Est. Cost/Share — Unrealized @ Report Date —
FATE FATE THERAPEUTICS INC 0.9%
Value $125M Shares 3,125,000 Share Price $39.97 Est. Cost/Share — Unrealized @ Report Date —
HWM HOWMET AEROSPACE INC 0.8%
Value $121M Shares 7,210,388 Share Price $16.72 Est. Cost/Share — Unrealized @ Report Date —
— LIVONGO HEALTH INC 0.8%
Value $116M Shares 830,000 Share Price $140.05 Est. Cost/Share — Unrealized @ Report Date —
— BRISTOL-MYERS SQUIBB CO 0.7%
Value $99.16M Shares 44,073,000 Share Price $2.25 Est. Cost/Share — Unrealized @ Report Date —
CI CIGNA CORP NEW 0.6%
Value $85.08M Shares 502,231 Share Price $169.41 Est. Cost/Share — Unrealized @ Report Date —
SRPT SAREPTA THERAPEUTICS INC 0.6%
Value $84.26M Shares 600,000 Share Price $140.43 Est. Cost/Share — Unrealized @ Report Date —
— MAXIM INTEGRATED PRODS INC 0.6%
Value $83.16M Shares 1,230,000 Share Price $67.61 Est. Cost/Share — Unrealized @ Report Date —
— MOMO INC 0.6%
Value $82.59M Shares 104,077,000 Share Price $0.79 Est. Cost/Share — Unrealized @ Report Date —
ENTA ENANTA PHARMACEUTICALS INC 0.6%
Value $81.26M Shares 1,775,000 Share Price $45.78 Est. Cost/Share — Unrealized @ Report Date —
NVCR NOVOCURE LTD 0.6%
Value $80.7M Shares 725,000 Share Price $111.31 Est. Cost/Share — Unrealized @ Report Date —
— FIBROGEN INC 0.5%
Value $76.07M Shares 1,850,000 Share Price $41.12 Est. Cost/Share — Unrealized @ Report Date —
— KANSAS CITY SOUTHERN 0.5%
Value $71.25M Shares 394,000 Share Price $180.83 Est. Cost/Share — Unrealized @ Report Date —
— BROADMARK RLTY CAP INC 0.5%
Value $70.7M Shares 7,170,213 Share Price $9.86 Est. Cost/Share — Unrealized @ Report Date —
APLS APELLIS PHARMACEUTICALS INC 0.5%
Value $68.64M Shares 2,275,000 Share Price $30.17 Est. Cost/Share — Unrealized @ Report Date —
PCG PG&E CORP 0.5%
Value $68.47M Shares 7,292,042 Share Price $9.39 Est. Cost/Share — Unrealized @ Report Date —
— GENERATION BIO CO 0.5%
Value $65.55M Shares 2,120,625 Share Price $30.91 Est. Cost/Share — Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 0.4%
Value $64.18M Shares 1,050,000 Share Price $61.12 Est. Cost/Share — Unrealized @ Report Date —
EFX EQUIFAX INC 0.4%
Value $62.21M Shares 396,484 Share Price $156.90 Est. Cost/Share — Unrealized @ Report Date —
— IQIYI INC 0.4%
Value $59.12M Shares 61,762,000 Share Price $0.96 Est. Cost/Share — Unrealized @ Report Date —
GRFS GRIFOLS S A 0.4%
Value $54.28M Shares 3,128,750 Share Price $17.35 Est. Cost/Share — Unrealized @ Report Date —
— KARUNA THERAPEUTICS INC 0.4%
Value $54.12M Shares 700,000 Share Price $77.32 Est. Cost/Share — Unrealized @ Report Date —
PTGX PROTAGONIST THERAPEUTICS INC 0.4%
Value $53.76M Shares 2,750,000 Share Price $19.55 Est. Cost/Share — Unrealized @ Report Date —
— THERAVANCE BIOPHARMA INC 0.3%
Value $49.81M Shares 56,695,000 Share Price $0.88 Est. Cost/Share — Unrealized @ Report Date —
— ARENA PHARMACEUTICALS INC 0.3%
Value $47.11M Shares 629,886 Share Price $74.79 Est. Cost/Share — Unrealized @ Report Date —
— KARYOPHARM THERAPEUTICS INC 0.3%
Value $46.69M Shares 38,523,000 Share Price $1.21 Est. Cost/Share — Unrealized @ Report Date —
CYTK CYTOKINETICS INC 0.3%
Value $46.55M Shares 2,150,000 Share Price $21.65 Est. Cost/Share — Unrealized @ Report Date —
— AMYRIS INC 0.3%
Value $40.88M Shares 14,000,000 Share Price $2.92 Est. Cost/Share — Unrealized @ Report Date —
ANNX ANNEXON INC 0.3%
Value $40.39M Shares 1,657,261 Share Price $24.37 Est. Cost/Share — Unrealized @ Report Date —
— ZOGENIX INC 0.3%
Value $40.34M Shares 2,250,000 Share Price $17.93 Est. Cost/Share — Unrealized @ Report Date —
PACB PACIFIC BIOSCIENCES CALIF IN 0.3%
Value $40.11M Shares 4,063,770 Share Price $9.87 Est. Cost/Share — Unrealized @ Report Date —
— ZYMEWORKS INC 0.3%
Value $39.7M Shares 852,200 Share Price $46.58 Est. Cost/Share — Unrealized @ Report Date —
AGIO AGIOS PHARMACEUTICALS INC 0.3%
Value $37.92M Shares 1,083,429 Share Price $35.00 Est. Cost/Share — Unrealized @ Report Date —
— CLOVIS ONCOLOGY INC 0.3%
Value $36.27M Shares 51,910,000 Share Price $0.70 Est. Cost/Share — Unrealized @ Report Date —
LNTH LANTHEUS HLDGS INC 0.2%
Value $33.58M Shares 2,650,000 Share Price $12.67 Est. Cost/Share — Unrealized @ Report Date —
— GLOBAL BLOOD THERAPEUTICS IN 0.2%
Value $33.08M Shares 600,000 Share Price $55.14 Est. Cost/Share — Unrealized @ Report Date —
ZNTL ZENTALIS PHARMACEUTICALS INC 0.2%
Value $32.4M Shares 991,174 Share Price $32.69 Est. Cost/Share — Unrealized @ Report Date —
— IQIYI INC 0.2%
Value $32.28M Shares 29,689,000 Share Price $1.09 Est. Cost/Share — Unrealized @ Report Date —
— CARA THERAPEUTICS INC 0.2%
Value $28.63M Shares 2,250,000 Share Price $12.72 Est. Cost/Share — Unrealized @ Report Date —
— INVITAE CORP 0.2%
Value $25.73M Shares 593,472 Share Price $43.35 Est. Cost/Share — Unrealized @ Report Date —
— RADIUS HEALTH INC 0.2%
Value $23.9M Shares 2,107,400 Share Price $11.34 Est. Cost/Share — Unrealized @ Report Date —
— BROADMARK RLTY CAP INC 0.2%
Value $23.58M Shares 2,391,536 Share Price $9.86 Est. Cost/Share — Unrealized @ Report Date —
— CORELOGIC INC 0.2%
Value $23.35M Shares 345,000 Share Price $67.67 Est. Cost/Share — Unrealized @ Report Date —
BEKE KE HLDGS INC 0.1%
Value $20.54M Shares 335,000 Share Price $61.30 Est. Cost/Share — Unrealized @ Report Date —
KRYS KRYSTAL BIOTECH INC 0.1%
Value $20.45M Shares 475,000 Share Price $43.05 Est. Cost/Share — Unrealized @ Report Date —
ADAPY ADAPTIMMUNE THERAPEUTICS PLC 0.1%
Value $20.08M Shares 2,515,762 Share Price $7.98 Est. Cost/Share — Unrealized @ Report Date —
— ZEALAND PHARMA A/S 0.1%
Value $19.19M Shares 505,000 Share Price $38.00 Est. Cost/Share — Unrealized @ Report Date —
ARWR ARROWHEAD PHARMACEUTICALS IN 0.1%
Value $18.24M Shares 423,600 Share Price $43.06 Est. Cost/Share — Unrealized @ Report Date —
PLRX PLIANT THERAPEUTICS INC 0.1%
Value $17.29M Shares 764,262 Share Price $22.62 Est. Cost/Share — Unrealized @ Report Date —
— DECIPHERA PHARMACEUTICALS IN 0.1%
Value $16.93M Shares 330,000 Share Price $51.30 Est. Cost/Share — Unrealized @ Report Date —
QURE UNIQURE NV 0.1%
Value $16.57M Shares 450,000 Share Price $36.83 Est. Cost/Share — Unrealized @ Report Date —
— ADVERUM BIOTECHNOLOGIES INC 0.1%
Value $15.45M Shares 1,500,000 Share Price $10.30 Est. Cost/Share — Unrealized @ Report Date —
RC READY CAPITAL CORP 0.1%
Value $15.12M Shares 1,350,226 Share Price $11.20 Est. Cost/Share — Unrealized @ Report Date —
AUPH AURINIA PHARMACEUTICALS INC 0.1%
Value $14.73M Shares 1,000,000 Share Price $14.73 Est. Cost/Share — Unrealized @ Report Date —
DMTKQ DERMTECH INC 0.1%
Value $14.58M Shares 1,219,999 Share Price $11.95 Est. Cost/Share — Unrealized @ Report Date —
— AVROBIO INC 0.1%
Value $13.67M Shares 1,050,000 Share Price $13.02 Est. Cost/Share — Unrealized @ Report Date —
CMPS COMPASS PATHWAYS PLC 0.1%
Value $12.67M Shares 362,940 Share Price $34.90 Est. Cost/Share — Unrealized @ Report Date —
— NAVISTAR INTL CORP NEW 0.1%
Value $12.04M Shares 276,600 Share Price $43.54 Est. Cost/Share — Unrealized @ Report Date —
ATTOF ATENTO S A 0.1%
Value $12M Shares 2,230,357 Share Price $5.38 Est. Cost/Share — Unrealized @ Report Date —
— HORIZON THERAPEUTICS PUB L 0.1%
Value $11.65M Shares 150,000 Share Price $77.68 Est. Cost/Share — Unrealized @ Report Date —
WTW WILLIS TOWERS WATSON PLC LTD 0.1%
Value $10.44M Shares 50,000 Share Price $208.82 Est. Cost/Share — Unrealized @ Report Date —
RCUS ARCUS BIOSCIENCES INC 0.1%
Value $9.427M Shares 550,000 Share Price $17.14 Est. Cost/Share — Unrealized @ Report Date —
LQDA LIQUIDIA TECHNOLOGIES INC 0.1%
Value $9.178M Shares 1,865,350 Share Price $4.92 Est. Cost/Share — Unrealized @ Report Date —
TARA PROTARA THERAPEUTICS INC 0.0%
Value $7.153M Shares 425,000 Share Price $16.83 Est. Cost/Share — Unrealized @ Report Date —
— INHIBRX INC 0.0%
Value $7.11M Shares 395,000 Share Price $18.00 Est. Cost/Share — Unrealized @ Report Date —
— ALBIREO PHARMA INC 0.0%
Value $6.674M Shares 200,000 Share Price $33.37 Est. Cost/Share — Unrealized @ Report Date —
— ALPINE IMMUNE SCIENCES INC 0.0%
Value $6.516M Shares 741,290 Share Price $8.79 Est. Cost/Share — Unrealized @ Report Date —
IVA INVENTIVA SA 0.0%
Value $6.229M Shares 527,870 Share Price $11.80 Est. Cost/Share — Unrealized @ Report Date —
— RADIUS HEALTH INC 0.0%
Value $5.474M Shares 6,783,000 Share Price $0.81 Est. Cost/Share — Unrealized @ Report Date —
SVRA SAVARA INC 0.0%
Value $4.853M Shares 4,452,086 Share Price $1.09 Est. Cost/Share — Unrealized @ Report Date —
— ARYA SCIENCES ACQUISTION CO 0.0%
Value $4.428M Shares 402,523 Share Price $11.00 Est. Cost/Share — Unrealized @ Report Date —
— IVERIC BIO INC 0.0%
Value $4.257M Shares 754,740 Share Price $5.64 Est. Cost/Share — Unrealized @ Report Date —
— ACACIA COMMUNICATIONS INC 0.0%
Value $4.044M Shares 60,000 Share Price $67.40 Est. Cost/Share — Unrealized @ Report Date —
EQ EQUILLIUM INC 0.0%
Value $4.039M Shares 700,000 Share Price $5.77 Est. Cost/Share — Unrealized @ Report Date —
DYN DYNE THERAPEUTICS INC 0.0%
Value $4.038M Shares 200,000 Share Price $20.19 Est. Cost/Share — Unrealized @ Report Date —
— APELLIS PHARMACEUTICALS INC 0.0%
Value $3.83M Shares 3,522,000 Share Price $1.09 Est. Cost/Share — Unrealized @ Report Date —
— QUOTIENT LTD 0.0%
Value $3.213M Shares 625,000 Share Price $5.14 Est. Cost/Share — Unrealized @ Report Date —
CRDF CARDIFF ONCOLOGY INC 0.0%
Value $2.838M Shares 200,000 Share Price $14.19 Est. Cost/Share — Unrealized @ Report Date —
— FUSION PHARMACEUTICALS INC 0.0%
Value $2.255M Shares 187,600 Share Price $12.02 Est. Cost/Share — Unrealized @ Report Date —
— BROADMARK RLTY CAP INC 0.0%
Value $2.063M Shares 7,174,613 Share Price $0.29 Est. Cost/Share — Unrealized @ Report Date —
— AMERICAN WELL CORP 0.0%
Value $1.334M Shares 45,000 Share Price $29.64 Est. Cost/Share — Unrealized @ Report Date —
— PANDION THERAPEUTICS INC 0.0%
Value $1.146M Shares 100,000 Share Price $11.46 Est. Cost/Share — Unrealized @ Report Date —
— GOL LINHAS AEREAS INTELIGENT 0.0%
Value $524K Shares 85,838 Share Price $6.10 Est. Cost/Share — Unrealized @ Report Date —